Premium · 21+Age Verification
You must be 21 years old or 18 years old with a medical card to access this website.
Are you eligible?
We're sorry!
You're not old enough to visit Weevader. Please come back when you're 21.
Premium · 21+You must be 21 years old or 18 years old with a medical card to access this website.
Are you eligible?
You're not old enough to visit Weevader. Please come back when you're 21.
Cannabis is one of the most widely discussed and frequently misunderstood substances in the world. Decades of prohibition created a fog of misinformation that persists even as legalization spreads and scientific research accelerates. From the 'gateway drug' theory to the idea that all strains are basically the same, let's separate fact from fiction using the best available evidence.
The gateway drug theory suggests that using cannabis leads to harder drug use. This was a cornerstone of anti-drug campaigns for decades, but the scientific evidence does not support a causal link. The National Institute on Drug Abuse (NIDA) itself states that 'the majority of people who use marijuana do not go on to use other, harder substances.'
What the data actually shows is that correlation is not causation. People who try cannabis are statistically more likely to try other substances, but this is likely due to shared risk factors (genetics, environment, socioeconomic conditions) rather than cannabis itself causing progression. In countries where cannabis has been legalized, there has been no observed increase in hard drug use. In fact, some studies suggest legal cannabis access may reduce opioid use.
This myth originated from a widely cited 1974 study that exposed rhesus monkeys to extreme amounts of cannabis smoke (the equivalent of 63 joints in five minutes, which essentially suffocated the animals). Subsequent research using proper methodology has not replicated these findings.
Modern neuroimaging studies show that adult cannabis use does not cause structural brain damage. A large 2019 study using MRI data from over 1,000 participants found no association between cannabis use and brain volume or cortical thickness in adults over age 25. However, research does suggest that heavy use during adolescence (before age 18) may affect brain development — which is why age restrictions exist. See our responsible use guide for more on youth and cannabis.
This is demonstrably false. Cannabis strains differ significantly in their cannabinoid profiles (THC, CBD, CBG, CBN levels), terpene compositions, and resulting effects. A high-THC, myrcene-dominant indica produces a very different experience from a balanced THC:CBD, limonene-dominant sativa.
Lab testing consistently shows wide variation between strains. THC levels can range from 5% to 35%, CBD from trace amounts to 20%+, and terpene profiles vary enormously. These chemical differences translate to different effects, onset times, durations, and medical applications. Browse strains on WeedVader to compare profiles yourself.
The indica/sativa classification is one of the most persistent myths in cannabis. Botanically, indica and sativa describe the plant's physical structure — indica plants are short and bushy, sativa plants are tall and thin. These physical traits do not reliably predict effects.
What actually determines effects is the chemical profile — the specific combination of cannabinoids and terpenes. An 'indica' strain high in limonene and terpinolene may be quite energizing, while a 'sativa' high in myrcene and linalool may be deeply sedating. The cannabis science community increasingly recommends classifying strains by their chemotype (chemical profile) rather than the outdated indica/sativa taxonomy.
Cannabis is less addictive than alcohol, nicotine, or opioids, but the claim that it is 'not addictive at all' is incorrect. The DSM-5 recognizes Cannabis Use Disorder (CUD) as a diagnosable condition. Approximately 10% of people who try cannabis develop CUD, and the rate rises to about 30% among regular users.
Cannabis withdrawal symptoms — while not life-threatening — are real and include irritability, insomnia, decreased appetite, anxiety, and restlessness. These symptoms typically begin 1-2 days after cessation and can last 1-3 weeks. Acknowledging this risk is not anti-cannabis — it's informed, responsible use.
The 'appeal to nature' fallacy suggests that because cannabis is a plant, it must be inherently safe. While cannabis has a remarkably good safety profile compared to many substances (no recorded fatal overdoses from cannabis alone), 'natural' does not mean risk-free.
This is perhaps the most commercially damaging myth in legal cannabis. Many consumers shop exclusively by THC percentage, but research and industry experts consistently point out that THC percentage alone is a poor predictor of experience quality.
A 2020 study from the University of Colorado found that participants who consumed high-potency concentrates (70%+ THC) did not report feeling significantly more intoxicated than those who consumed flower (20-25% THC). The entourage effect suggests that terpenes and minor cannabinoids play a crucial role in shaping the experience. A well-grown 18% THC strain with a rich terpene profile can provide a more enjoyable, nuanced experience than a poorly grown 30% THC strain.
THC-induced anxiety and paranoia are real phenomena, but they are not universal. Whether you experience anxiety from cannabis depends on dose, strain, your individual endocannabinoid system, genetics (specifically CB1 receptor gene variants), tolerance, and your environment. Learn more in our cannabis and anxiety guide.
Many people use cannabis specifically for anxiety relief and find it effective at appropriate doses. The key factor is the biphasic effect of THC: low doses tend to reduce anxiety, while high doses increase it. CBD also buffers THC's anxiety-inducing potential, which is why balanced THC:CBD strains are recommended for anxiety-prone individuals.
There are zero confirmed deaths from a cannabis-only overdose in recorded medical history. The estimated lethal dose of THC in humans (based on animal studies) would require consuming approximately 1,500 pounds of cannabis in 15 minutes — a physical impossibility.
However, 'you can't fatally overdose' does not mean 'there are no consequences to taking too much.' Consuming excessive THC can produce extremely unpleasant symptoms: severe anxiety, paranoia, nausea, vomiting, rapid heart rate, disorientation, and incapacitation. While not life-threatening, these experiences are genuinely distressing and should be taken seriously.
Smoking and vaping cannabis are not equivalent in terms of health impact. Smoking combusts plant material at temperatures above 600 C, producing tar, carbon monoxide, and many of the same carcinogenic compounds found in tobacco smoke. Vaporizing heats cannabis to 160-220 C — hot enough to release cannabinoids and terpenes but below the combustion point.